Skip to content
Medical Health Aged Care

New JAHA-Published EggNest® Study and Texas State Regulatory Variance Validate Shift Toward Apron-Free Workflows in the Interventional Lab

Egg Medical, Inc. 2 mins read

MINNEAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Egg Medical today announced the publication of a prospective study in the Journal of the American Heart Association (JAHA) evaluating its EggNest Enhanced Radiation Protection Devices (ERPDs). Conducted at The Christ Hospital in Cincinnati, OH, the real-world clinical study demonstrates that radiation protection allows interventional lab personnel to perform procedures safely without heavy personal lead aprons.

Validating these clinical findings in practice, the Texas Department of State Health Services recently granted a state radiation variance to Methodist Healthcare System of San Antonio.

"The EggNest system protects the entire team so they can choose to go apron-free or wear ultralight aprons that feel like a light vest," said Dr. Santiago Garcia, interventional cardiologist at The Christ Hospital and principal investigator of the study. "This comprehensive data provides interventional teams with an evidence-based pathway to significantly reduce orthopedic strain while enhancing radiation safety."

Key Findings Published in JAHA

  • Apron-Free Reduction: The estimated annual collar dose for primary operators dropped from 86.7 mRem with standard shielding to 25.5 mRem with EggNest Complete (p < 0.001). For context, according to the CDC, a 5-6 hour flight yields radiation exposure of ~3.5 mRem.
  • Minimal Exposure Across All Roles: With the EggNest Complete ERPD, total effective doses for all lab roles, including primary operators, scrub assistants, and circulating nurses, were 1% of the ICRP annual maximum (5,000 mRem).
  • Ultralight Apron Performance: Pairing EggNest ERPDs with ultralight (0.125 mm) aprons yielded significantly lower annualized radiation doses than wearing traditional heavy (0.5 mm) aprons with standard shielding. The primary operator received an annualized EDE-1 dose of 51.4 mRem under 0.5mm lead aprons with standard shielding vs. 1.4 mRem under 0.125 lead aprons with EggNest Complete (p < 0.001).

"The radiation reduction we achieve with EggNest fundamentally changes how we approach lab safety—I feel completely comfortable working apron-free," said Dr. Tim Henry, Medical Director of The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital and past president of SCAI. "It clears the way for a healthier, more sustainable future for operators and staff."

Lead-Free, Responsibly

Egg Medical emphasizes a flexible, safety-first philosophy: Lead-Free, Responsibly. Modern interventional labs are not one-size-fits-all, and EggNest technology is engineered to support apron-optional workflows where approved—never to force a single standard of practice.

Contact: Susan Storm, [email protected]

A photo is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f11b7fd7-ba99-49e4-bf36-92a14d2f6c78


Primary Logo

More from this category

  • Medical Health Aged Care
  • 22/10/2026
  • 03:07
Future Health - A Global Initiative by Abu Dhabi

Future Health and Bridge for Billions to Launch Programme Strengthening Health Entrepreneurship in Emerging Markets

New programme will support locally rooted health entrepreneurs to build stronger ventures and deepen their impact in the communities they serve The programme responds…

  • Contains:
  • Medical Health Aged Care
  • 22/10/2026
  • 00:01
Distributed by Lanham Media on behalf of the National Allergy Council

Think you’re allergic to penicillin? It may be worth checking

Strictly embargoed until 12.01am Thursday October 22, 2026 Australians who have been told they are allergic to penicillin are being encouraged to discuss it with their doctor, with research showing up to nine in 10 people with a reported penicillin allergy are not allergic when properly assessed.¹ Around 10% of people report a penicillin allergy – equivalent to approximately 2.8 million Australians based on the current population – yet fewer than 1% of the population are thought to be truly allergic.¹ ² Professor Michaela Lucas, a Clinical Immunology/Allergy Specialist and Co-chair of the National Allergy Council’s Drug Allergy Working Group…

  • Medical Health Aged Care
  • 21/10/2026
  • 23:07
Baszucki Group

Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital

Baszucki Group funding awarded to McLean Hospital to establish a flagship clinical and research center, and jointly to McLean and MH² for medical education…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.